Share Price | Baird Medical Investment Holdings Ltd. Stock Analysis & Recommendation

Q: Is Baird Medical Investment Holdings Ltd. technically bullish or bearish?

As of 1 October 2023, the technical stance for Baird Medical Investment Holdings Ltd. is bearish overall, with mixed signals across different indicators. The MACD shows a mildly bullish trend on the weekly but is bearish on the monthly. The RSI indicates bullish momentum on the weekly, but there is no signal on the monthly. Bollinger Bands and moving averages are both mildly bearish on the weekly, with the daily moving averages also indicating a bearish stance. KST and Dow Theory are bearish and mildly bullish respectively on the weekly, while OBV is mildly bullish. In terms of performance, the stock has returned 20.66% over the past month compared to the S&P 500's 2.33%, but it has significantly underperformed over longer periods, with a year-to-date return of -66.18% versus the S&P 500's 12.22%.

Price Point

High/Low

1Day

52 Week

Valuation

Technical

Day's Volume

CASH

73.64 k

Shareholding (Jun 2025)

FII

1.54%

Held by 6 FIIs

DII

97.47%

Held by 1 DIIs

Promoter

0.00%

Is Baird Medical Investment Holdings Ltd. technically bullish or bearish?

20-Sep-2025

As of October 1, 2023, Baird Medical Investment Holdings Ltd. has a bearish overall technical stance with mixed signals, showing a 20.66% return over the past month but a significant year-to-date decline of -66.18% compared to the S&P 500's 12.22%.

View full answer

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

Dashboard

Unrated Stock - No Analysis Available

Mojo Parameters

Stock DNA

Industry

Pharmaceuticals & Biotechnology

Market cap

USD 84 Million (Micro Cap)

P/E

NA (Loss Making)

Industry P/E

Dividend Yield

0.00%

Debt Equity

0.57

Return on Equity

-999,999.00%

Price to Book

2.37

Revenue and Profits:

Net Sales:

(Quarterly Results - Jun 2024)

Net Profit:

-1 Million

Total Returns

Total Returns (Price + Dividend)

TimePeriod

Price Return

Dividend Return

Total Return

3 Months

39.71%

6 Months

-11.21%

1 Year

-66.13%

2 Years

-82.63%

3 Years

-81.71%

4 Years

-80.94%

5 Years

0.0%

Baird Medical Investment Holdings Ltd. for the last several years.

Risk Adjusted Returns v/s

News & Corporate Actions

News

No Recent News for the Company

Announcements

No announcement available

Corporate Actions

No corporate action available

Key Factors

Quality key factors

Factor

Value

Sales Growth (5y)

236.30%

EBIT Growth (5y)

157.28%

EBIT to Interest (avg)

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

Sales to Capital Employed (avg)

Tax Ratio

Tax Ratio is Negative%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

13.41%

ROCE (avg)

ROE (avg)

Valuation key factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

2.37

EV to EBIT

-17.19

EV to EBITDA

-17.19

EV to Capital Employed

1.87

EV to Sales

PEG Ratio

Dividend Yield

ROCE (Latest)

-10.90%

ROE (Latest)

-13.71%

Technicals key factors

Indicator

Weekly

Monthly

MACD

Mildly Bullish

RSI

Bearish

No Signal

Bollinger Bands

Mildly Bullish

Bearish

Moving Averages

Mildly Bearish (Daily)

KST

Bullish

Bearish

Dow Theory

Mildly Bullish

No Trend

OBV

Mildly Bullish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Shareholding

Shareholding Snapshot : Jun 2025

Shareholding Compare (%holding)

Majority shareholders

Foreign Institutions

Domestic Funds

Held in 5 Schemes (0.99%)

Foreign Institutions

Held by 6 Foreign Institutions (1.54%)

Strategic Entities with highest holding

Highest Public shareholder

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Jun'24 - QoQ",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "QoQ Growth in quarter ended Jun 2024 is 0.00% vs 0.00% in Mar 2024",
        "dir": 0
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "QoQ Growth in quarter ended Jun 2024 is 43.75% vs -128.57% in Mar 2024",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Jun'24",
        "Mar'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-1.00",
          "val2": "-1.80",
          "chgp": "44.44%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-0.90",
          "val2": "-1.60",
          "chgp": "43.75%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.00%",
          "val2": "0.00%",
          "chgp": "NA",
          "chgp_class": "neutral"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2024 is 17.46% vs 0.00% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2024 is 17.76% vs 1,683.33% in Dec 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "37.00",
          "val2": "31.50",
          "chgp": "17.46%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "16.80",
          "val2": "13.20",
          "chgp": "27.27%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.60",
          "val2": "0.30",
          "chgp": "100.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "12.60",
          "val2": "10.70",
          "chgp": "17.76%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "413.50%",
          "val2": "377.10%",
          "chgp": "3.64%",
          "chgp_class": "positive"
        }
      ]
    }
  }
]